AAAAAA
Results: 1-25/27
Authors:
Bonlokke, L
Hovgaard, L
Kristensen, HG
Knutson, L
Lennernas, H
Citation: L. Bonlokke et al., Direct estimation of the in vivo dissolution of spironolactone, in two particle size ranges, using the single-pass perfusion technique (Loc-I-Gut (R)) in humans, EUR J PH SC, 12(3), 2001, pp. 239-250
Authors:
Takamatsu, N
Kim, ON
Welage, LS
Idkaidek, NM
Hayashi, Y
Barnett, J
Yamamoto, R
Lipka, E
Lennernas, H
Hussain, A
Lesko, L
Amidon, GL
Citation: N. Takamatsu et al., Human jejunal permeability of two polar drugs: Cimetidine and ranitidine, PHARM RES, 18(6), 2001, pp. 742-744
Authors:
Krondahl, E
von Euler-Chelpin, H
Orzechowski, A
Ekstrom, G
Lennernas, H
Citation: E. Krondahl et al., In vitro metabolism of opioid tetrapeptide agonists in various tissues andsubcellular fractions from rats, PEPTIDES, 22(4), 2001, pp. 613-621
Authors:
Lagerquist, C
Beigi, F
Karlen, A
Lennernas, H
Lundahl, P
Citation: C. Lagerquist et al., Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography, J PHARM PHA, 53(11), 2001, pp. 1477-1487
Authors:
Engman, HA
Lennernas, H
Taipalensuu, J
Otter, C
Leidvik, B
Artursson, P
Citation: Ha. Engman et al., CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies, J PHARM SCI, 90(11), 2001, pp. 1736-1751
Authors:
Lepist, EI
Kusk, T
Larsen, DH
Andersen, D
Frokjaer, S
Taub, ME
Veski, P
Lennernas, H
Friedrichsen, G
Steffansen, B
Citation: Ei. Lepist et al., Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter, EUR J PH SC, 11(1), 2000, pp. 43-50
Authors:
Pedersen, BL
Brondsted, H
Lennernas, H
Christensen, FN
Mullertz, A
Kristensen, HG
Citation: Bl. Pedersen et al., Dissolution of hydrocortisone in human and simulated intestinal fluids, PHARM RES, 17(2), 2000, pp. 183-189
Authors:
Krondahl, E
Von Euler-Chelpin, H
Orzechowski, A
Ekstrom, G
Lennernas, H
Citation: E. Krondahl et al., Investigations of the in-vitro metabolism of three opioid tetrapeptides bypancreatic and intestinal enzymes, J PHARM PHA, 52(7), 2000, pp. 785-795
Authors:
Danelian, E
Karlen, A
Karlsson, R
Winiwarter, S
Hansson, A
Lofas, S
Lennernas, H
Hamalainen, MD
Citation: E. Danelian et al., SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans, J MED CHEM, 43(11), 2000, pp. 2083-2086
Authors:
Lennernas, H
Citation: H. Lennernas, Animal perfusion studies, DRUG PHARM, 106, 2000, pp. 73-98
Authors:
Lennernas, H
Citation: H. Lennernas, Human perfusion studies, DRUG PHARM, 106, 2000, pp. 99-117
Authors:
Lepist, EI
Ostergaard, J
Fredholt, K
Lennernas, H
Friis, GJ
Citation: Ei. Lepist et al., Stability and perfusion studies of Desmopressin (dDAVP) and prodrugs in the rat jejunum, EXP TOX PAT, 51(4-5), 1999, pp. 363-368
Authors:
Schipper, NGM
Varum, KM
Stenberg, P
Ocklind, G
Lennernas, H
Artursson, P
Citation: Ngm. Schipper et al., Chitosans as absorption enhancers of poorly absorbable drugs 3: Influence of mucus on absorption enhancement, EUR J PH SC, 8(4), 1999, pp. 335-343
Authors:
Bonlokke, L
Hovgaard, L
Kristensen, HG
Knutson, L
Lindahl, A
Lennernas, H
Citation: L. Bonlokke et al., A comparison between direct determination of in vivo dissolution and the deconvolution technique in humans, EUR J PH SC, 8(1), 1999, pp. 19-27
Authors:
Steffansen, B
Lepist, EI
Taub, ME
Larsen, BD
Frokjaer, S
Lennernas, H
Citation: B. Steffansen et al., Stability, metabolism and transport of D-Asp(OBzl)-Ala - a model prodrug with affinity for the oligopeptide transporter, EUR J PH SC, 8(1), 1999, pp. 67-73
Authors:
Nilsson, D
Lennernas, H
Fasth, KJ
Sundin, A
Tedroff, J
Aquilonius, SM
Hartvig, P
Langstrom, B
Citation: D. Nilsson et al., Absorption of L-DOPA from the proximal small intestine studied in the rhesus monkey by positron emission tomography., EUR J PH SC, 7(3), 1999, pp. 185-189
Authors:
Sandstrom, E
Lennernas, H
Ohlen, K
Karlsson, A
Citation: E. Sandstrom et al., Enantiomeric separation of verapamil and norverapamil using Chiral-AGP (R)as the stationary phase, J PHARM B, 21(1), 1999, pp. 43-49
Authors:
Lindahl, A
Persson, B
Ungell, AL
Lennernas, H
Citation: A. Lindahl et al., Surface activity and concentration dependent intestinal permeability in the rat, PHARM RES, 16(1), 1999, pp. 97-102
Authors:
Sandstrom, R
Knutson, TW
Knutson, L
Jansson, B
Lennernas, H
Citation: R. Sandstrom et al., The effect of ketoconazole on the jejunal permeability and CYP3A metabolism of (R/S)-verapamil in humans, BR J CL PH, 48(2), 1999, pp. 180-189
Authors:
Sandstrom, R
Lennernas, H
Citation: R. Sandstrom et H. Lennernas, Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats, DRUG META D, 27(8), 1999, pp. 951-955
Authors:
Svensson, USH
Sandstrom, R
Carlborg, O
Lennernas, H
Ashton, M
Citation: Ush. Svensson et al., High in situ rat intestinal permeability of artemisinin unaffected by multiple dosing and with no evidence of P-glycoprotein involvement, DRUG META D, 27(2), 1999, pp. 227-232
Authors:
Fagerholm, U
Nilsson, D
Knutson, L
Lennernas, H
Citation: U. Fagerholm et al., Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag, ACT PHYSL S, 165(3), 1999, pp. 315-324
Authors:
Sandstrom, R
Karlsson, A
Lennernas, H
Citation: R. Sandstrom et al., The absence of stereo selective P-glycoprotein-mediated transport of R/S-verapamil across the rat jejunum, J PHARM PHA, 50(7), 1998, pp. 729-735
Authors:
Lindahl, A
Sandstrom, R
Ungell, AL
Lennernas, H
Citation: A. Lindahl et al., Concentration- and region-dependent intestinal permeability of fluvastatinin the rat, J PHARM PHA, 50(7), 1998, pp. 737-744
Authors:
Kaukonen, AM
Lennernas, H
Mannermaa, JP
Citation: Am. Kaukonen et al., Water-soluble beta-cyclodextrins in paediatric oral solutions of spironolactone: Preclinical evaluation of spironolactone bioavailability from solutions of beta-cyclodextrin derivatives in rats, J PHARM PHA, 50(6), 1998, pp. 611-619